Open · 929 days left D National Institutes of Health

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)

Funding
Not specified
Deadline
--
Days
--
Hrs
--
Min
--
Sec
Sep 07, 2028
Posted Jun 13, 2025 (252 days ago)
Closes Sep 7, 2028 (in 929 days)

Grant Details

Opportunity Number
PAR-25-414
CFDA / ALN
93.113, 93.121, 93.172, 93.173, 93.242, 93.273, 93.279, 93.286, 93.307, 93.361, 93.398, 93.846, 93.847, 93.853, 93.855, 93.859, 93.865, 93.866, 93.867, 93.879
Opportunity Category
Discretionary (D)
Funding Category
ED, ENV, FN, HL, ISS
Funding Instrument
Grant (G)
Cost Sharing
No Cost Sharing (No)

Eligibility

Public and State controlled institutions of higher education (06) Private institutions of higher education (20)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Description

The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who are not currently funded by any NIH Research Project Grants (RPGs) with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.